| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | May 16, 2025 | PERRIGO Co plc | Director | Sell | 22.5 | -4,754 | -12.99% | ✗ | $123.7K |
| May 15, 2024 | May 16, 2024 | PERRIGO Co plc | Director | Sell | 22.5 | -4,207 | -14.17% | ✗ | $127.1K |
| May 17, 2023 | May 19, 2023 | PERRIGO Co plc | Director | Sell | 22.5 | -3,734 | -14.44% | ✗ | $122.7K |
| Nov 22, 2022 | Nov 23, 2022 | Theravance Biopharma, Inc. | Director | Sell | 22.5 | -10,000 | -18.56% | ✗ | $105K |
| May 17, 2022 | May 19, 2022 | PERRIGO Co plc | Director | Sell | 22.5 | -3,168 | -14.91% | ✗ | $122.2K |
| May 7, 2021 | May 11, 2021 | PERRIGO Co plc | Director | Sell | 22.5 | -2,786 | -15.98% | ✗ | $119.7K |
| May 15, 2020 | May 19, 2020 | PERRIGO Co plc | Director | Sell | 22.5 | -2,906 | -19.98% | ✗ | $153.3K |
| May 16, 2019 | May 20, 2019 | Theravance Biopharma, Inc. | Director | Sell | 22.5 | -4,000 | -12.67% | ✗ | $81.8K |
| May 15, 2019 | May 17, 2019 | PERRIGO Co plc | Director | Sell | 22.5 | -1,907 | -18.35% | ✗ | $94.5K |
| Jun 6, 2018 | Jun 8, 2018 | PERRIGO Co plc | Director | Sell | 22.5 | -2,218 | -25.67% | ✗ | $162.4K |
| May 31, 2017 | Jun 2, 2017 | PERRIGO Co plc | Director | Sell | 22.5 | -1,697 | -27.94% | ✗ | $123.6K |
| May 4, 2016 | May 6, 2016 | PERRIGO Co plc | Director | Sell | 26.3 | -481 | -14.62% | ✗ | $46K |
| Nov 13, 2015 | Nov 17, 2015 | PERRIGO Co plc | Director | Sell | 22.5 | -1,004 | -29.78% | ✗ | $147.5K |
| Nov 13, 2015 | Nov 17, 2015 | PERRIGO Co plc | Director | Sell | 22.5 | -926 | -27.47% | ✗ | $136K |